Skip to main content
. 2020 Jan 1;11(2):272–283. doi: 10.7150/jca.34965

Figure 1.

Figure 1

Expression of CD105 in human placental choriocarcinoma cell line (JEG-3), MTX-resistant choricarcinoma cell line (JEG-3/MR) and FUDR-resistant choricarcinoma cell line (JEG-3/FR). Western blotting (A), qRT-PCR (B) and immunofluorescence (C) analysis confirmed the overexpression of CD105 in JEG-3/MR and JEG-3/FR cells. The image C is at ×600 magnification.